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ABSTRACT
The pioneer (or first) round of translation of newly
synthesized mRNAs is largely mediated by a nuclear
cap-binding complex (CBC). In a transcriptome-wide
analysis of polysome-associated and CBC-bound
transcripts, we identify RN7SL1, a noncoding RNA
component of a signal recognition particle (SRP), as
an interaction partner of the CBC. The direct CBC–
SRP interaction safeguards against abnormal ex-
pression of polypeptides from a ribosome–nascent
chain complex (RNC)–SRP complex until the latter is
properly delivered to the endoplasmic reticulum. Fail-
ure of this surveillance causes abnormal expression
of misfolded proteins at inappropriate intracellular lo-
cations, leading to a cytosolic stress response. This
surveillance pathway also blocks protein synthesis
through RNC–SRP misassembled on an mRNA en-
coding a mitochondrial protein. Thus, our results re-
veal a surveillance pathway in which pioneer transla-
tion ensures proper targeting of endoplasmic reticu-
lum and mitochondrial proteins.
INTRODUCTION
Approximately 30% of newly synthesized proteins in eu-
karyotic cells are integral membrane proteins or secretory
proteins, both of which should be transported to the sur-
face or lumen of the endoplasmic reticulum (ER) (1). Ac-
cumulating evidence shows that selection of a protein des-
tined for membrane integration or secretion proceeds co-
translationally in the eukaryotic cell (2–7). As a nascent
polypeptide chain emerges from the exit tunnel of an elon-
gating ribosome, the N-terminal signal sequence composed
of hydrophobic residues is co-translationally recognized
by the signal recognition particle (SRP), which is pre-
associated with the ribosome (8–11). The resulting complex
composed of the ribosome–nascent chain complex (RNC)
and the SRP is translationally arrested or delayed until it
binds to the SRP receptor (SR), a heterodimer of SR and
SR located on the ER surface. Once the RNC–SRP com-
plex is properly delivered to the ER, the SR binds to the
SRP through heterodimerization of the NG domain (com-
posed of a helical N-domain and a central GTPase domain)
of SRP54 (a component of SRP) and the NG domain of
SR, triggering dissociation of SRP from the complex. The
remaining RNC is then transferred to a translocon (Sec61
complex) (12) and eventually resumes translation elonga-
tion (2,3,7,11,13).
The mammalian SRP is composed of a single noncod-
ing (nc) RNA (7SL RNA; RN7SL1) and six polypeptides,
including SRP54, forming two functional domains (8–11).
The Alu domain of SRP is involved in translational arrest
of the RNC. The S domain recognizes the signal sequence
in the RNC and binds to the SR in a GTP-dependent man-
ner. In particular, the universally conserved SRP54 protein
binds to the exit tunnel of the ribosome via its NG domain
and recognizes the signal sequence through its methionine-
rich M domain.
Due to the hydrophobic property of the N-terminal sig-
nal sequence, improper targeting of integral membrane pro-
teins and secretory proteins often causes misfolding and/or
aggregation of a nascent polypeptide and consequently in-
duces proteotoxic stress (6,14–17). Therefore, to minimize
mistargeting and aberrant synthesis of proteins destined
for the ER, eukaryotic cells have evolved several quality
control mechanisms operating at either mRNA or global
levels (18). For instance, when an N-terminal signal se-
quence lacks a sufficient number of hydrophobic residues,
the nascent chain in the RNC preferentially binds to Arg-
onaute 2 (AGO2) rather than SRP (19). The mRNA in the
resulting RNC–AGO2 complex is subjected to rapid degra-
dation by unknown nuclease(s) in a process termed regu-
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lation of aberrant protein production (RAPP). In this way,
the RAPP pathway selectively degrades mRNAs encoding
aberrant signal sequences. An ER-associated protein degra-
dation pathway and a regulated IRE-1–dependent mRNA
decay pathway, which act as quality control mechanisms at
the global level, are activated by the accumulating misfolded
proteins in the ER, reducing global translation efficiency
and levels of mRNAs encoding secretory proteins, respec-
tively (18).
It is widely accepted that newly synthesized mRNAs
being exported from the nucleus are largely subject to
the pioneer (or the first) round of translation (pioneer
translation) mediated by a nuclear cap-binding complex
[CBC; a heterodimer of cap-binding proteins (CBPs) 80
and 20] (20,21). Pioneer translation is mostly involved in
mRNA surveillance rather than active protein synthesis
(20–22). For instance, an aberrant mRNA harboring a
premature termination codon (PTC) is rapidly degraded
by nonsense-mediated mRNA decay (NMD), the best-
characterized mRNA surveillance mechanism (23,24), with
most of the degradation occurring during pioneer trans-
lation (22). In contrast, when an mRNA is normal and
thus passes the mRNA surveillance pathway during pio-
neer translation, a cytoplasmic cap-binding protein called
eukaryotic translation initiation factor 4E (eIF4E) replaces
the CBC with the help of importins (IMPs)  and  in
a translation-independent manner (25–27). The resulting
eIF4E-associated messenger ribonucleoprotein (mRNP)
then participates in active protein synthesis.
In this study, we present compelling evidence for a CBC-
ensured quality control pathway via which the CBC re-
presses inadequate translation from the RNC–SRP com-
plex until the complex is properly delivered to the ER.
MATERIALS AND METHODS
Plasmid construction
The following plasmids were used in this study: pCMV-Myc
and pEGFP-C2 (Clontech); p3×FLAG-CMV™-7.1 (Mil-
liporeSigma); pCMV-Myc-ER-GFP (Invitrogen); pCMV-
Myc-GFP (28); pcDNA3-FLAG, pcDNA3-FLAG-CTIF,
pcDNA3-FLAG-CBP80 and pmCMV-GPx1-Norm (29);
pX (30); pCMV-Myc-eIF4E and pRGl-SL0-Norm (31);
pcDNA3.1-HA and pN-HA-GFP (27); pCXbsr-mRFP-
Ub and pCMV-Myc-GST (32); pMS2-HA-GFP (33);
pCMV3-IMP-FLAG (Sino Biological; #HG17676-CF);
pOTB7-SRP54, pCMV-SPORT6-SR, pCMV-SPORT6-
DPM3, pOTB7-PAM16, pCMV-SPORT6-SLC25A41 and
pOTB7-ATP5F1E (ATP5E; Korea Human Gene Bank;
hMU006286, hMU001253, hMU003974, hMU008804,
hMU004511 and hMU005976, respectively); Lamp1-RFP
(Addgene; #1817), mCh-Sec61 (Addgene; #49155);
pcDNA3.1-FLAG-LC3B (a kind gift from Hyun Kyu
Song, Korea University, Republic of Korea) and pWT-
PPL-TET (19).
To construct plasmids pcDNA3-FLAG-CBP80(1–307), -
CBP80(308–790) and -CBP80(664–790), the corresponding
regions of human CBP80 complementary DNAs (cDNAs)
were PCR-amplified using pcDNA3-FLAG-CBP80 as
the template and two specific oligonucleotides as primers:
5′-GACTACAAGGACGACGATGACAAGGCG-3′
(sense) and 5′-CCCAAGCTTTTAACTCCCTGGCA
TGACAGGACCCTCGGG-3′ (antisense) for amplifica-
tion of the 1–307 region; 5′-CGCGGATCCGATGTC
AGTGGAAAGATTTGTAATAGAAGAG-3′ (sense)
and 5′-TGATCAGCGGTTTAAACTTAAGCTTTTA-3′
(antisense) for amplification of the 308–790 region; and 5′-
CGGGATCCGGAGAAACTTGCTAGGCAACACAA
ACGG-3′ (sense) and the same antisense oligonucleotide
that was used to amplify the 308–790 region for amplifi-
cation of the 664–790 region. The underlined nucleotides
specify the BamHI and HindIII restriction enzyme sites,
respectively. Each PCR-amplified fragment was ligated to
a BamHI/HindIII fragment of pcDNA3-FLAG.
To generate plasmid pcDNA3.1-CBP80-HA, the
NheI/XhoI fragment of pcDNA3.1-HA was ligated to the
NheI/XhoI fragment containing human CBP80 cDNA,
which was PCR-amplified using pcDNA3-FLAG-CBP80
as the template and two oligonucleotides as primers:
5′-CTAGCTAGCGCCACCATGTCGCGGCGGCGGC
ACAGCGACGAGA-3′ (sense) and 5′-CCGCTCGAGCG
GCCTGCAGGGCACAGAACTGCTGGAACA-3′ (an-
tisense). The underlined nucleotides represent the NheI
and XhoI restriction sites, respectively.
To construct plasmids pcDNA3.1-CBP80-L34E-
HA, -L254E-HA and -L264E-HA, leucine at positions
34, 254 and 264 of CBP80 were replaced with glu-
tamic acid. Then, pcDNA3.1-CBP80R-WT-HA and
CBP80R-L34E-HA plasmids expressing an siRNA-
resistant (R) version of CBP80-WT-HA and CBP80-
L34E-HA, respectively, were generated by changing the
specific target sequences annealing to CBP80 siRNA
from 5′-GGAAGAAGCUAAAGAGAAA-3′ to 5′-
AGAGGAGGCAAAGGAAAAG-3′, where the under-
lined nucleotides represent the silent mutation sites that
confer resistance to CBP80 siRNA.
To generate pcDNA3.1-CBP80-(23–790)-HA encoding
the N-terminal deletion mutant of CBP80 that does not
interact with IMP (26), the NheI/ApaI fragment of
pcDNA3.1-HA was ligated to a PCR product ampli-




(antisense) as primers. The underlined nucleotides specify
the NheI restriction site.
To construct the plasmid pcDNA3.1-SRP54-HA encod-
ing full-length human SRP54 cDNA, the NheI/XhoI frag-
ment of pcDNA3.1-HA was ligated to the PCR-amplified
NheI/XhoI fragment containing SRP54 cDNA. PCR was
carried out using pOTB7-SRP54 as the template and two
oligonucleotides as primers: 5′-CTGGCTAGCGCCACC
ATGGTTCTAGCAGACCTTGGAAG-3′ (sense) and 5′-
TGGCTCGAGTCATATTATTGAATCCCATCATG-3′
(antisense), where the underlined nucleotides denote the
NheI and XhoI restriction sites, respectively.
To construct p3 × FLAG-SRP54-FL, -NG and -M,
the corresponding regions of human SRP54 cDNA
were amplified by PCR, using pOTB7-SRP54 as the
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CGGGGTACCAATGGTTCTAGCAGACCTTGGAAG-
3′ (sense for FL and NG), 5′-CGGGGTACCAATG
CTTCTTGGTATGGGCGACATTG-3′ (sense for M),
5′-TCCCCCGGGTTACATATTATTGAATCCCATCAT
GC-3′ (antisense for FL and M), and 5′-TCCCCCGGGTT
ATTTGCTAATAAAAGGCTGTGTTTTG-3′ (antisense
for NG). The underlined nucleotides specify KpnI and
SmaI restriction sites, respectively. Each PCR-amplified
fragment was ligated to the KpnI/SmaI fragment of
p3×FLAG.
To generate plasmids pCMV-Myc-SR-SRX and -
NG, the corresponding regions of human SRα cDNA
were PCR-amplified using pCMV-SPORT6-SR as a
template and the following specific oligonucleotides:
5′-ACGCGTCGACCATGCTCGACTTCTTCACCATT
TTCTCCAAG-3′ (sense for SRX), 5′-CGGGGTACCTT
ACTTGGTCGCACTAGGTTTGGTAGAGTTTTG-3′
(antisense for SRX), 5′-ACGCGTCGACCGGAACAC
TGGGTGGCATGTTTGGTATGCTG-3′ (sense for
NG), and 5′-CGGGGTACCTTAAGCCTTCATGA
GGGCAGCCACCACAGC-3′ (antisense for NG). The
underlined nucleotides represent SalI and KpnI sites,
respectively. Each PCR-amplified fragment was ligated to
the SalI/KpnI fragment of pCMV-Myc.
To construct pX-CBP80-eYFP-10×His, which encodes
human CBP80 fused to the C-terminus of 10×His-tagged
enhanced yellow fluorescent protein (eYFP), the eYFP-
10×His sequence was inserted into the pX vector. Then,
a PCR-amplified fragment containing CBP80 cDNA was
inserted at a SalI restriction site upstream of eYFP-10×His.
PCR was performed using pcDNA3-FLAG-CBP80 as the
template and two oligonucleotides: 5′-ACGCGTCGACAT
GTCGCGGCGGCGGCACAGCGACGAGAAC-3′
(sense) and 5′-GCCGACGTCGACGGCCTGCAGGGC
ACAGAACTGCTGGAACAC-3′ (antisense), where the
underlined nucleotides denote the SalI restriction site.
To construct pX-CBP20-Protein G, which encodes
human CBP20 fused at the C-terminus of protein G,
the protein G sequence was inserted into the pX vec-
tor. Next, a PCR-amplified fragment containing CBP20
cDNA was inserted at SalI and XbaI sites upstream of
the protein G gene. PCR was carried out using a plasmid
harboring human CBP20 cDNA (29) as the template
and two oligonucleotides: 5′-ACGCGTCGACATGT
CGGGTGGCCTCCTGAAGGCGCTGCGC-3′ (sense)
and 5′-TGCTCTAGACTGGTTCTGTGCCAGYYY
YCCATAGCCTCC-3′ (antisense), where the underlined
nucleotides specify the SalI and XbaI restriction sites,
respectively.
To generate pXFlagR-SRP54-NG for the purifica-
tion of recombinant protein on the -Flag M1 anti-
body resin (MilliporeSigma), a sequence containing
10×His-FLAG-multicloning site-mCherry-10 × His
was inserted into pX. Next, the PCR-amplified DNA
fragment corresponding to the N-terminal segment of
human SRP54 (residues 1–293; SRP54-NG) was in-
serted into the multicloning sites (XhoI/XbaI sites).
PCR was conducted using p3×FLAG-SRP54-NG
as the template and specific oligonucleotides: 5′-
CCGCTCGAGATGGTTCTAGCAGACCTTGGAAG-3′
(sense) and 5′-TGCTCTAGATTTGCTAATAAAAG
GCTGTGTTTTG-3′ (antisense), where the underlined
nucleotides represent the XhoI and XbaI restriction sites,
respectively.
To construct pcDNA3-FLAG-GFP, the BamHI/HindIII
fragment of pcDNA3-FLAG was ligated to a PCR-
amplified fragment containing the full-length GFP cDNA
that was digested with BamHI and HindIII. The GFP




CGTCCATGCCGAGAGTG-3′ (antisense), where the
underlined nucleotides specify the BamHI and HindIII
sites, respectively.
To generate plasmids pCon-RGl and pPPL-RGl, the
5′ untranslated region of pRGl-SL0-Norm was replaced
with a fragment harboring either Con or PPL sequences,
respectively, obtained from pWT-PPL-TET.
To construct pCon-FLAG-GPx1 and pPPL-FLAG-
GPx1, we first generated p3×FLAG-GPx1 by inserting a
GPx1 genomic sequence (obtained from pmCMV-GPx1-
Norm) into p3xFLAG. Then, Con and PPL sequences
obtained from pCon-RGl and pPPL-RGl, respectively,
were inserted immediately upstream of the FLAG sequence
of p3 × FLAG-GPx1.
To construct pCMV-DPM3-GFP, pCMV-PAM16-GFP,
pCMV-SLC25A41-GFP and pCMV-ATP5E-GFP (which
encode either the ER- or mitochondria-targeted protein),
the Myc sequences in pCMV-Myc-GFP were replaced with
full-length cDNA sequences of human DPM3, PAM16,
SLC25A41 or ATP5E, respectively.
To construct pN-HA-GST, the XbaI/NotI fragment
of pN-HA-GFP was ligated to a PCR-amplified DNA
fragment encoding full-length GST that was digested
with XbaI and NotI. The GST sequence was PCR-
amplified from a pCMV-Myc-GST template using two
oligonucleotides: 5′-GCTCTAGAGATGGCCCCTATAC
TAGGTTATTGGAAAATTAAG-3′ (sense) and 5′-CTG
CATTCTAGTTGTGGTTTGTCCAAACTCATC-3′ (an-
tisense), where the underlined nucleotides specify the XbaI
site.
All PCRs were carried out using the Advantage-HF2
PCR Kit (Clontech). All constructs were verified by se-
quencing.
Cell culture
HeLa (female; ATCC), HEK293T (fetal; ATCC), HEK293-
EBNA (fetal; ATCC) and HEK293FT cells (fetal; ATCC)
were maintained in Dulbecco’s modified Eagle’s medium
(DMEM; Capricorn Scientific) supplemented with
10% fetal bovine serum (Capricorn Scientific) and 1%
penicillin/streptomycin (Capricorn Scientific). To prevent
mycoplasma contamination, all cultured cells were regu-
larly treated with Plasmocin™ (Invivogen) and analyzed
using the MycoAlert PLUS Mycoplasma Detection Kit
(Lonza).
For heat shock experiments, HeLa cells were subjected to
heat shock treatment by incubating at 42◦C for 30 min and
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DNA or siRNA transfection
Cells were transiently transfected with various plasmids
using either calcium phosphate method or Lipofectamine
2000 (Thermo Fisher Scientific), as described previously
(33,34).
For siRNA transfection, the cells were transfected with
100 nM in vitro-synthesized siRNAs (GenePharma) using
either Oligofectamine (Thermo Fisher Scientific) or Lipo-
fectamine 3000 (Thermo Fisher Scientific), as described
previously (33,34). The following siRNA sequences were
used for specific downregulation of endogenous proteins:
5′-r(AAAUUUGGUAAGAACAAUG)d(TT)-3′ (SRα
siRNA), 5′-r(UAUUGUUGACUCUGUAUAC)d(TT)-
3′ (SRβ siRNA), 5′-r(GGAAGAAGCUAAAGAG
AAA)d(TT)-3′ (CBP80 siRNA), 5′-r(CAGGUUGU
UCAUAGUCAGAAU)d(TT)-3′ (HSF1 siRNA), and
5′-r(ACAAUCCUGAUCAGAAACC)d(TT)-3′ (nonspe-
cific control siRNA).
RNA preparation, reverse transcription PCR (RT-PCR) and
quantitative RT-PCR (qRT-PCR)
Details of RNA preparation, cDNA synthesis, and RT-
PCR analyses have been described elsewhere (33,34).
Briefly, total cell RNA isolated using TRIzol Reagent (Life
Technologies) was subjected to DNA digestion using 0.05
U/l DNase I (Thermo Fischer Scientific) at 37◦C for 45
min. Purified RNA was incubated with 6 U/l RevertAid
reverse transcriptase (Thermo Fisher Scientific) at 37◦C
for 2 h. After the reaction, qRT-PCR was conducted us-
ing the reverse-transcribed cDNA, gene-specific oligonu-
cleotides (Supplementary Table S1), and the LightCycler
480 SYBR Green I Master Kit (Roche), as described previ-
ously (33,34). qRT-PCR analysis was performed according
to the MIQE guidelines (35).
Western blotting, immunoprecipitation (IP) and RNA-
immunoprecipitation (RNA-IP) assays
Antibodies against the following proteins were used for
western blotting or IP: CBP80 (36), eIF4E [cat. # 2067,
Cell Signaling Technology (rabbit), or cat. # 610269, BD
Biosciences (mouse) for western blotting], eIF3b (sc-16377,
Santa Cruz Biotechnology), -actin (A5441, Millipore-
Sigma), eIF4GI (29), IMP (A300-484A, Bethyl Labora-
tories), SRP72 (NBP1-89498, Novus Biologicals), SRP68
(11585–1-AP, Proteintech), SRP54 (610940, BD Bio-
sciences), SRP19 (16033-1-AP, Proteintech), SRP9 (11195-
1-AP, Proteintech), SR (H00006734-B02P, Novus Bi-
ologicals), SR (NBP2-02028, Novus Biologicals), p53
(2524, Cell Signaling Technology), Y14 (MAB2484, Ab-
nova), MAGOH (ab38768, Abcam), DCP1A (D5444, Mil-
liporeSigma), G3BP1 (13057-2-AP, Proteintech), HSF1
(4356, Cell Signaling Technology), phospho-Ser326-HSF1
(ab76076, Abcam), FLAG (-DYKDDDDK, 14793, Cell
Signaling Technology or A8592, MilliporeSigma), Myc
(9E10; OP10L, MilliporeSigma), GFP (sc-9996, Santa Cruz
Biotechnology) and HA (11867431001, Roche). For all
eIF4E IP assays except the experiment in Figure 1A and
Supplementary Figure S1A and B, we used an in-house -
eIF4E antibody (27). The IP assays depicted in Figure 1A
and Supplementary Figure S1A and B were carried out us-
ing a commercial -eIF4E antibody (sc-9976, Santa Cruz
Biotechnology).
The following secondary antibodies were used for west-
ern blotting: horseradish peroxidase (HRP)-conjugated
goat -mouse IgG antibody (AP124P, MilliporeSigma),
HRP-conjugated goat -rabbit IgG antibody (AP132P,
MilliporeSigma), HRP-conjugated rabbit -goat IgG anti-
body (A5420, MilliporeSigma) and HRP-conjugated goat
-rat IgG antibody (ab6845, Abcam).
IP and RNA-IP assays were performed as previously
described (33,34). Where indicated, the cells were treated
with 3.7% formaldehyde (Millipore Sigma) in phosphate-
buffered saline (PBS) for 10 min. Bead-bound proteins and
mRNAs were assayed using western blotting and qRT-
PCR, respectively.
Signal intensities of western blot bands were quantitated
using ImageJ software (version 1.5, National Institutes of
Health).
Recombinant protein purification
To purify the CBC, HEK293-EBNA cells were tran-
siently co-transfected with two plasmids: pX-CBP80-
eYFP-10×His and pX-CBP20-Protein G. Dimethyl sulfox-
ide (Amresco) was added immediately after the transfec-
tion to get a final concentration of 1%, and the temper-
ature was lowered to 33◦C. Two days after transfection,
tryptone (Amresco) was added to get a final concentration
of 0.5%. Three days after transfection, the cells were har-
vested and resuspended in buffer A [20 mM Tris–HCl (pH
7.5), 250 mM NaCl, and 2 mM -mercaptoethanol] supple-
mented with 10% glycerol, 2 g/ml staphylococcal nuclease,
5 mM CaCl2, 1 mM PMSF and one tablet of EDTA-Free
Pierce™ Protease Inhibitor Tablets (Thermo Fisher Scien-
tific). The resuspended cells were lysed by sonication. The
supernatant was separated by centrifugation, loaded onto a
Ni-NTA column (Qiagen), and washed with buffer A sup-
plemented with 40 mM imidazole (MilliporeSigma). Bound
proteins were eluted with buffer A supplemented with 200
mM imidazole. The eluted proteins were then loaded onto a
HiTrap™ Q HP column (GE Healthcare) equilibrated with
a buffer consisting of 20 mM Tris–HCl (pH 7.5), 100 mM
NaCl, and 2 mM -mercaptoethanol. The column-bound
proteins were eluted using a NaCl gradient of 100–500
mM. The fractions containing the CBC were collected and
treated overnight with His-tagged human rhinovirus 3C
protease to cleave the junctions between CBP80 and eYFP-
10×His and between CBP20 and protein G. Each protease-
treated sample was loaded onto the Ni-NTA column again
to remove His-tagged proteases, eYFP-10×His, and other
protein impurities with substantial Ni-binding affinity. Ap-
proximately half of the CBC proteins passed through the
column, while the other half bound weakly to the resin and
were eluted using buffer A supplemented with 20 mM imi-
dazole. The flow-through and eluted fractions were pooled,
concentrated to 1.7 mg/ml, and then purified further us-
ing a HiLoad 16/600 Superdex 200 pg column (GE Health-
care) equilibrated with buffer B [20 mM Tris–HCl (pH 7.5),
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(0.6 mg/ml) was flash-frozen in liquid nitrogen and stored
at −80◦C.
To purify FLAG-SRP54-NG, HEK293-EBNA cells
grown in suspension were transiently transfected with
pXFlagR-SRP54-NG. SRP54-NG was expressed as a fu-
sion protein with the 10×His-FLAG tag at the N-terminus
and the mCherry-10×His tag at the C terminus. The protein
was produced using a protocol similar to that described for
CBC purification. The cell extract was loaded onto a Ni-
NTA column. Eluted proteins were treated overnight with
tobacco etch virus protease and HRV 3C protease to ex-
pose the FLAG tag at the N-terminus and to remove the
C-terminal mCherry-10×His, respectively. The sample was
mixed with -FLAG M1 agarose resin (MilliporeSigma) in
the presence of 5 mM CaCl2 under slow rotation at 4◦C for
1 h. After washing with buffer A supplemented with 1 mM
CaCl2, bound proteins were eluted using buffer A supple-
mented with 5 mM EGTA. The eluted FLAG-SRP54-NG
was concentrated to 0.2 mg/ml and further purified using a
HiLoad 16/600 Superdex 200 pg column equilibrated with
buffer B. The peak fraction was concentrated to 0.4 mg/ml,
flash-frozen in liquid nitrogen and stored at −80◦C.
In vitro pull-down assay
Purified CBC (2.9 M) or FLAG-SRP54-NG (2.4 M) was
mixed with -FLAG M1 agarose resin (MilliporeSigma)
in the presence or absence of 5 mM MgCl2 and/or 4 mM
GMP-PNP (MilliporeSigma) in binding buffer consisting
of buffer B and 5 mM CaCl2. After 10 min of incubation
with rotation at 4◦C, each mixture was centrifuged, and
unbound fractions collected separately. The protein-bound
resin was washed three times with binding buffer only or
binding buffer containing 5 mM MgCl2 or 4 mM GMP-
PNP. The unbound fractions and the resin-bound proteins
from each experiment were loaded onto a gel for SDS-
PAGE.
In vitro reconstitution assay
To prepare FLAG-tagged proteins, HEK293T cells were
transiently transfected with a plasmid expressing either
FLAG-GFP or IMP-FLAG. Two days later, IP assays
were conducted using FLAG M2 affinity gels (Milli-
poreSigma). The bead-bound FLAG-tagged proteins were
eluted with a 3×FLAG peptide (MilliporeSigma).
To prepare IMP–CBC-associated mRNPs, HEK293T
cells expressing a reporter mRNA were depleted of SR.
The cell extracts were subjected to RNA-IP at 4◦C for 3 h
with either rIgG or -CBP80 antibody pre-conjugated to
protein A agarose 4B beads (Incospharm). After incuba-
tion, the beads were washed five times with NET2 buffer
[50 mM Tris–HCl (pH 7.4), 150 mM NaCl, 1 mM PMSF,
2 mM benzamidine and 0.05% NP-40] supplemented with
100 U/ml RNase inhibitor (Thermo Fisher Scientific).
The bead-bound RNPs were resuspended in NET2 buffer
and mixed with the eluted FLAG-tagged proteins (either
FLAG-GFP or IMP-FLAG) for 20 min at 37◦C. The
bead-bound and unbound fractions were then separated
through centrifugation. Before RNA purification, in vitro-
transcribed FLuc RNA molecules were added as a spike-in
to both fractions.
Far-western blotting
This procedure was carried out using either purified recom-
binant proteins and immunopurified FLAG-SRP54-FL or
its variant. Briefly, purified recombinant proteins were re-
solved using SDS-PAGE and transferred to a Hybond ECL
nitrocellulose membrane (GE Healthcare). Each membrane
was incubated in blocking buffer [100 mM Tris–HCl (pH
7.5), 100 mM potassium acetate, 2 mM magnesium acetate,
0.1 mM EDTA (pH 8.0), 10% glycerol, 1 mM PMSF, 1
mM benzamidine and 0.05% Tween 20] supplemented with
5% skimmed milk at 4◦C for 24 h. The membranes were
then incubated in blocking buffer containing immunopuri-
fied FLAG-SRP54-FL or its variants at 4◦C for an addi-
tional 24 h. Finally, the membranes were analyzed by west-
ern blotting using HRP-conjugated -FLAG antibody.
Immunostaining
HeLa cells, either undepleted or depleted of both SR and
CBP80, were transfected with various plasmids. Two days
after plasmid transfection, the cells were fixed with 3.65–
3.8% formaldehyde (MilliporeSigma) for 30 min. The fixed
cells were permeabilized with 0.5% Triton X-100 (Milli-
poreSigma) for 10 min and then blocked with 1.5% bovine
serum albumin (BSA; Bovogen, BSAS 0.1). The permeabi-
lized cells were incubated first with a primary antibody in
PBS containing 0.5% BSA and then with a rhodamine-
conjugated goat -rabbit IgG secondary antibody (31670,
Thermo Fisher Scientific) and Alexa Fluor 488-conjugated
goat -mouse IgG secondary antibody (A-11017, Invitro-
gen).
Mitochondria were stained by incubating cells in a pre-
warmed medium containing 500 nM MitoTracker (Thermo
Fisher Scientific) for 30 min at 37◦C. The cells were then
washed with ice-cold PBS and fixed as described above.
Imaging was performed using an LSM 700 or LSM 800
Carl Zeiss microscope. The images were processed using the
ZEN software (Zeiss). Fluorescence intensities of the im-
ages were quantitated using ImageJ.
In situ proximity ligation assay (PLA)
This assay was performed using the in situ Proximity Lig-
ation Assay Kit (MilliporeSigma), following the manu-
facturer’s instructions. Briefly, the cells were fixed with
formaldehyde and permeabilized with 0.5% Triton X-100
in PBS. The permeabilized cells were incubated in blocking
buffer at 37◦C for 1 h and then probed with primary an-
tibodies in antibody diluent buffer at 37◦C for 1 h. After
washing, the cells were incubated for 1 h with secondary
antibodies conjugated with either a PLUS or MINUS
PLA probe [Duolink® In Situ PLA® Probe Anti-Mouse
PLUS (MilliporeSigma; DUO82001) and Duolink® In
Situ PLA® Probe Anti-Rabbit MINUS (MilliporeSigma;
DUO82005)] at 37◦C. The PLA probes were ligated in liga-
tion buffer at 37◦C for 30 min and amplified in a polymerase
mixture with rolling circle amplification Green buffer at
37◦C for 100 min. Finally, the cells were stained with DAPI
and imaged using an LSM 800 confocal microscope (Carl
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50 cells were counted from three biological replicates, and
the number of PLA puncta was counted using ImageJ. P
values were computed using Wilcoxon’s signed-rank test.
Determination of intracellular ADP/ATP ratio
This ratio was measured in HEK293T cells (1 × 103) using
the ADP/ATP Ratio Assay Kit (MilliporeSigma) accord-
ing to the manufacturer’s instructions. Briefly, cells were in-
cubated in ATP reagent for 1 min, and luminescence was
quantified as a metric of the amount (A) of ATP. After incu-
bation for an additional 10 min, background luminescence
was quantified again prior to ADP measurement (B). ADP
was quantified by adding an ADP-converting enzyme (C).
The ADP/ATP ratio was calculated as follows: ADP/ATP
ratio = (C − B)/A.
Measurement of mitochondrial membrane potential
Mitochondrial membrane potential was measured in
HEK293T cells using the TMRE Mitochondrial Mem-
brane Potential Assay Kit (BioVision), according to the
manufacturer’s instructions. Cells (1 × 104) were cultured
in a 96-well plate. Three days after siRNA transfection, the
cells were incubated with 200 nM TMRE at 37◦C for 30
min in the dark. After that, the cells were washed three times
with 100 l assay buffer. Fluorescent signals were measured
at excitation/emission wavelengths of 549/575 nm using a
fluorescence microplate reader (Bio-Rad).
Generation of cell lines
HEK293FT cells stably expressing Myc-eIF4E were gen-
erated by cotransfection with a plasmid expressing Myc-
eIF4E and a plasmid expressing a puromycin resistance
gene. Two days after transfection, the cells were serially
diluted and maintained in DMEM supplemented with 1
g/ml puromycin (MilliporeSigma) until distinct colonies
formed. Independent colonies were isolated and subjected
to western blotting with either -eIF4E or -Myc anti-
bodies to determine the relative expression level of Myc-
eIF4E compared to endogenous eIF4E. The selected cell
lines were maintained in DMEM supplemented with 0.5
g/ml puromycin.
Polysome fractionation experiments
HEK293FT cells cultured in two 150 mm culture dishes
were harvested. The cytoplasmic extracts were assayed us-
ing polysome fractionation experiments, as described else-
where (29,37). Each pooled fraction was then subjected to
IP with various antibodies.
Where indicated, HEK293FT cells stably expressing
Myc-eIF4E were transfected with the indicated siRNAs.
One day after transfection, the cells were re-transfected with
various plasmids and two days later, polysomal fractiona-
tion experiments were conducted as described above.
DNA microarray analysis
This analysis was performed at eBiogen (Republic of Ko-
rea). HEK293FT cells were subjected to polysome fraction-
ation experiments and the polysomal fractions were pooled
for RNA-IP using either -CBP80 or -eIF4E antibodies.
Bound RNA was purified and converted to Cy3/5-labeled
complementary RNA (cRNA) using the Low RNA In-
put Linear Amplification Kit (Agilent Technologies). The
Cy3/5-labeled cRNA was then hybridized onto Agilent’s
Human Oligo Microarray (44 K human gene chip). Hy-
bridization images were captured using Agilent’s DNA mi-
croarray scanner and quantified using the Feature Extrac-
tion Software (Agilent Technologies). Data normalization
and selection of differentially expressed genes were per-
formed using GeneSpring GX 7.3 (Agilent Technologies).
The averages of normalized ratios were calculated by divid-
ing the average of normalized signal channel intensities by
the average of the normalized control channel intensities.
QuantSeq 3′ mRNA sequencing
Co-immunoprecipitated (Co-IPed) transcripts were ex-
tracted from CBP80 or SRP68 immunoprecipitates using
TRIzol Reagent. RNA quality was analyzed on an Agilent
2100 Bioanalyzer using the RNA 6000 Nano Chip (Agi-
lent Technologies). RNA quantity was measured using an
ND-2000 spectrophotometer (Thermo Scientific). RNA li-
braries were constructed using the QuantSeq 3′ mRNA Seq
Library Prep Kit (Lexogen) and then subjected to high-
throughput sequencing as single-end (1 × 75 bp) reads on
NextSeq 500 (Illumina) at eBiogen Inc.
Poly(A)+ high-throughput RNA sequencing (RNA-seq)
Poly(A)+ RNA-seq libraries were constructed and se-
quenced at Macrogen Inc. Poly(A)+ RNA was purified
using oligo-d(T)-conjugated magnetic beads. The libraries
were prepared using TruSeq Stranded mRNA Sample Prep
Kit (Illumina). The quality of the final libraries was tested
on an Agilent Bioanalyzer (DNA 1000 kit; Agilent Tech-
nologies). They were then quantified using qPCR (Kapa Li-
brary Quant Kit; Kapa Biosystems, Wilmington, MA). Li-
braries were sequenced in paired-end mode (2 × 100 bp) on
an Illumina HiSeq 2500 (Illumina, CA, USA).
Next-generation sequence data analysis
Reads obtained from QuantSeq were mapped to the hu-
man reference genome (hg19) using Bowtie2 (38). Bowtie2
indexes were generated either from the genome assembly se-
quence or from representative transcript sequences. Differ-
entially expressed genes were analyzed in Bedtools based on
read counts obtained from the alignment coverage (39).
To analyze Poly(A)+ RNA-seq data, adaptor sequences
were first trimmed from the reads using Cutadapt (40).
Reads over 15 bp long and with Phred quality scores higher
than 30 were selected. The processed reads were aligned to
the reference human genome (hg19) using STAR aligner
software (41). Read counts per gene were estimated using
the htseq-count Python code (42). Each RPM value was
used to normalize co-IPed RNA. The normalized values
(RPM of co-IPed RNA/RPM of input RNA) were filtered
based on a 1.0 cutoff. The filtered genes were classified into
two groups: ‘CBP80-bound mRNAs’ and ‘SRP68-bound
mRNAs’ (Figure 2D). CBP80-bound mRNAs in cells de-
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CBP80-bound mRNAs were categorized into three
groups: CBP80 IP (present in the CBP80 IP), CBP80 IP–
SRP68 IP (present only in the CBP80 IP but not in the
SRP68 IP), and CBP80 IP ∩ SRP68 IP (present in both
CBP80 IP and SRP68 IP and therefore able to form the
CBC–RNC–SRP complex). The log2 (siSRα/β ÷ siCon-
trol) value of each group was presented as a CDF plot.
Gene ontology (GO) analysis
A target group (fold change ≥ 1.5) was uploaded to DAVID
(43,44) and analyzed using the functional annotation tool.
GO terms from the cellular component category were used
in this study. The results file was retrieved, and the GO terms
and their corresponding P values were retrieved.
Statistical analysis
Two-tailed equal-variance Student’s t test was performed,
with significance defined as a P value <0.05 or <0.01. Data
are presented as the mean ± standard deviation.
For CDF analysis, P values were calculated using the two-
tailed Mann–Whitney U test. Pearson’s correlation coeffi-
cients (r) were calculated to determine correlation between
mRNA sequence data and QuantSeq data obtained from
two biological replicates.
P values associated with the quantification of PLA
puncta (Figure 6C) were computed using Wilcoxon’s
signed-rank test.
RESULTS
The CBC physically interacts with the SRP
We were curious about a possible difference in composition
between CBC-associated mRNAs and eIF4E-associated
mRNAs during their translation. To this end, pooled
polysomal fractions were separated into two fractions by
immunoprecipitation (IP) using either an anti- (-) CBP80
or an -eIF4E antibody (Supplementary Figure S1A). Mi-
croarray analysis of coimmunoprecipitated (co-IPed) tran-
scripts revealed that although most cellular mRNAs and
ncRNAs were associated with CBP80 and eIF4E in com-
parable ratios, subsets of mRNAs and ncRNAs were pref-
erentially enriched in the IPs of CBP80 (Figure 1A, Supple-
mentary Figure S1B, and Supplementary Table S2). One of
the top-ranked ncRNAs was RN7SL1, an ncRNA compo-
nent of the SRP complex (Figure 1A, Supplementary Fig-
ure S1C, and Supplementary Table S2B). The specific inter-
action between CBP80 and the SRP was evidenced using
different approaches: IPs (Supplementary Figures S2 and
S3A–D), far-western blotting (Figure 1B), and in vitro pull-
down assay using purified recombinant proteins (Figure
1C). Furthermore, on the basis of publicly available struc-
tural data on human SRP54 and SR (PDB: 5L3Q) (45)
and CBP80–CBP20–PGC1 complex (PDB: 6D0Y) (46),
we predicted three possible residues critical for the inter-
action between CBP80 and SRP54: L34, L254 and L264,
present at the N-terminal domain of CBP80 (residues 1–
307), since hydrophobic residues usually play a major role
in protein–protein interactions. These residues are located
on the protein surface and are expected to have minimal ef-
fect on protein folding. Among these, the L34E substitution
in CBP80 specifically disrupted its association with SRP54
(Figure 1D and Supplementary Figure S3E). These data in-
dicate that the CBC directly interacts with the SRP through
the N-terminal MIF4G domain of CBP80 and the NG do-
main of SRP54 (Figure 1E).
It is known that the NG domain of SRP54 directly in-
teracts with the NG domain of SR on the ER surface, al-
lowing the RNC–SRP complex to dock to the ER (47,48).
Based on our observations, we hypothesized that CBP80
may compete with SR for binding to SRP54 (Figure 1E).
In support of this hypothesis, SR downregulation increased
the association between CBP80 and SRP without affecting
the interaction between CBP80 and IMP (Figure 1F and
Supplementary Figure S4A). Furthermore, overexpression
of the NG domain, but not the SRX domain, of SR dis-
rupted the association between CBP80 and SRP54 (Supple-
mentary Figure S4B).
Inefficient targeting of RNC–SRP to the ER results in accu-
mulation of the CBC–RNC–SRP complex
We investigated changes in mRNP composition due to the
observed competition by employing a Renilla luciferase
(RLuc) reporter mRNA (Figure 2A) either lacking (Con-
RGl) or harboring (PPL-RGl) an ER-targeting signal
sequence (which interacts with the SRP) derived from a
secretory protein, preprolactin (hereafter referred to as
PPL) (19). CBC-associated and eIF4E-associated reporter
mRNPs were separated through IP, using either -CBP80
antibody or -eIF4E antibody. Although the amount of
CBP80-associated Con-RGl mRNA was affected only
marginally by SR downregulation, the amount of CBP80-
associated PPL-RGl mRNA was significantly increased
by this downregulation (Figure 2B and Supplementary Fig-
ure S5A). In contrast, no increase was observed for eIF4E-
associated Con-RGl or PPL-RGl mRNA (Figure 2B
and Supplementary Figure S5B). Notably, an increase in the
amount of CBP80-associated PPL-RGl mRNA was only
observed in the IP of CBP80-WT, but not of CBP80-L34E
(Supplementary Figure S5C and D). These results provide
evidence that inefficient binding of RNC–SRP to the SR
(caused by SR downregulation) results in specific accumu-
lation of mRNP (destined for ER) in the form of the CBC–
RNC–SRP complex (Figure 2C).
The specific accumulation was validated at the transcrip-
tome level (Figure 2D, E, and Supplementary Figure S6A–
D). We identified 2,778 mRNAs commonly enriched in two
biological replicates of the IP of CBP80 and 1922 mRNAs
commonly enriched in two biological replicates of the IP of
SRP68 (another component of the SRP) (Figure 2D and
Supplementary Table S3). The obtained mRNAs were cat-
egorized into three groups: CBP80 IP group (present in the
CBP80 IP), CBP80 IP – SRP68 IP group (present only in
the CBP80 IP but not in the SRP68 IP), and CBP80 IP ∩
SRP68 IP group (present in both CBP80 IP and SRP68 IP
and therefore able to form the CBC–RNC–SRP complex).
Based on cumulative distribution function (CDF) analysis,
the CBP80 IP ∩ SRP68 IP group showed a significant in-
crease in fold enrichment in the IP of CBP80 following SR
downregulation compared with the other groups (Figure
2E). These transcriptome data showed that mRNAs asso-
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Figure 1. The CBC directly interacts with the SRP. (A) The scatter plot of ncRNAs enriched in the IP of CBP80 and eIF4E (log2 scale). Co-IPed ncRNAs
obtained from two independently conducted polysome fractionation experiments followed by IP were studied by microarray analysis. (B) Far-western
blotting (FW) of purified recombinant proteins. (left) Coomassie blue staining of a purified recombinant CBC. (right) FW of immunopurified FLAG-
SRP54––either full-length (FL) or its deletion variant––as a probe; n = 2. (C) In vitro pull-down assays of purified recombinant proteins (the CBC and
FLAG-SRP54-NG) using -FLAG antibody. After pull-down, samples of bead-bound or unbound proteins were stained with Coomassie blue. GMP-PNP,
a nonhydrolyzable analog of GTP; *, heavy and light chains of IgG; n = 2. (D) IP of SRP54. IP with -FLAG antibody was carried out using extracts of
HEK293T cells transiently expressing FLAG-SRP54 and either CBP80-WT-HA or its variant. Levels of co-IPed CBP80-HA were normalized to those of
IPed FLAG-SRP54; n = 3. (E) Schematic representation of the domains in CBP80, SRP54, and SR. The arrows indicate domain interactions observed
in this or previous studies. MIF4G domain, the middle domain of eIF4G; NG domain, the helical N-domain and the central GTPase domain; M domain,
methionine-rich domain; SRX, SR-interacting domain. (F) IP of endogenous CBP80. IP was carried out using either -CBP80 antibody or, as a control,
rabbit IgG (rIgG), in the extracts of HEK293T cells either undepleted or depleted of either SR or SR; n = 2.
riched in the IP of CBP80 upon SR downregulation, sug-
gesting that inefficient binding of RNC–SRP to the SR
leads to preferential accumulation of the CBC–RNC–SRP
complex. This conclusion was further supported by evi-
dence showing preferential enrichment of endogenous mR-
NAs belonging to the CBP80 IP ∩ SRP68 IP group in the IP
of CBP80-WT, but not CBP80-L34E, upon SR downregu-
lation (Supplementary Figure S6E).
The CBC–RNC–SRP complex is resistant to IMP-
mediated mRNP remodeling
How does the inefficient binding of RNC–SRP to the SR
lead to accumulation of the CBC–RNC–SRP complex? We
noted that fewer CBP80 and IMP were enriched in the
IP of IMP following SR downregulation (Supplementary
Figure S7A and B), implying that the CBC–RNC–SRP
complex may not be favorable for IMP-mediated mRNP
remodeling (25,26).
To test this hypothesis, we conducted an in vitro reconsti-
tution assay (Figure 3 and Supplementary Figure S7C–F).
Either CBC-associated Con-RGl or PPL-RGl mRNP
was immunopurified by IP using -CBP80 antibody and ex-
tracts of cells either undepleted or depleted of SR (Figure
3A, right). In parallel, either transiently expressed IMP-
FLAG or FLAG-GFP (used as a control) was immunop-
urified and eluted from the beads (Figure 3A, left). The
eluted protein (IMP-FLAG or FLAG-GFP) was mixed
with CBC-associated mRNPs bound to agarose beads. For
CBC-associated Con-RGl mRNPs, the addition of IMP-
FLAG resulted in a ∼2-fold reduction in the amount of
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Figure 2. Downregulation of the SR results in accumulation of the CBC–RNC–SRP complex. (A) A schematic of reporter mRNAs. PPL, a signal sequence
derived from preprolactin. (B) Relative abundance of co-IPed reporter mRNAs in the IPs of either CBP80 (upper) or eIF4E (lower) following downreg-
ulation of either SR or SR in HEK293T cells. After the IPs, in vitro–transcribed firefly luciferase (FLuc) RNAs were added to each IP as a spike-in.
The levels of co-IPed reporter mRNAs were normalized to that of FLuc RNA; n = 4. *P < 0.05; **P < 0.01; n.s., not significant. (C) A schematic of the
CBC–RNC–SRP complex assembled on an mRNA encoding a signal sequence. (D) Venn diagrams showing the number of mRNAs enriched in the IP of
CBP80 or SRP68. Only mRNAs with reads per million (RPM) values over 1.0 were selected for further analysis. (E) A CDF plot showing relative changes
in the abundance of co-IPed mRNAs in CBP80 after SR downregulation. The P value was calculated using two-tailed Mann–Whitney U test.
undepleted or SR-depleted cells (Figure 3B), confirming
the efficient dissociation of mRNA from the CBC–mRNP
complex under our experimental conditions. In contrast, in
the case of CBC-associated PPL-RGl mRNPs, the addi-
tion of IMP-FLAG reduced the amount of bead-bound
reporter mRNAs immunopurified from undepleted cells,
but not from SR-depleted cells (Figure 3C). These results
suggest that the CBC–RNC–SRP complex is resistant to
IMP-mediated replacement of the CBC by eIF4E and thus
accumulates when RNC–SRP fails to interact with the SR
on the surface of the ER.
The CBC–RNC–SRP complex is translationally repressed
Next, we investigated the translational competence of the
accumulated CBC–RNC–SRP complex (Figure 4). Cy-
toplasmic extracts were prepared from either undepleted
or SR-depleted HEK293FT cells expressing Myc-eIF4E,
CBP80-HA, and reporter mRNAs (both Con-RGl and
PPL-RGl mRNAs) (Figure 4A). Subsequently, each frac-
tion obtained from the polysome fractionation experiments
was subjected to IP using either -HA antibody (for iso-
lation of CBC-associated mRNPs) or -Myc antibody (for
isolation of eIF4E-associated mRNPs) (Figure 4B).
The relative distribution of CBP80-associated PPL-
RGl mRNAs, but not eIF4E-associated PPL-RGl mR-
NAs, drastically shifted from polysomal to subpolyso-
mal fractions after SR downregulation (Figure 4C and
D). In contrast, the relative distribution of either CBP80-
or eIF4E-associated Con-RGl mRNAs was not signif-
icantly affected by SR downregulation (Figure 4E and
F), suggesting that CBC–RNC–SRP is a translationally re-
pressed complex. Remarkably, double downregulation of
both CBP80 and SR promoted preferential enrichment
of eIF4E-associated PPL-RGl mRNAs, but not eIF4E-
associated Con-RGl mRNAs, in the polysomal fractions
(Supplementary Figure S8), implying that a failure of the
interaction between the CBC and SRP causes an IMP-
mediated replacement of the CBC by eIF4E, consequently
promoting the translation of the resulting eIF4E–RNC–
SRP. These data indicate that inefficient targeting of RNC–
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Figure 3. The CBC–RNC–SRP complex is resistant to IMP-mediated
mRNP remodeling. In vitro reconstitution assays were performed using im-
munopurified proteins and IMP–CBC-associated mRNPs. (A) Schematic
of the experimental scheme for the in vitro reconstitution assay. To prepare
FLAG-GFP or IMP-FLAG, the IPs with -FLAG antibody–conjugated
agarose beads were carried out in extracts of HEK293T cells transiently
expressing either FLAG-GFP or IMP-FLAG. Bead-bound FLAG-GFP
or IMP-FLAG was eluted using the FLAG peptide. To prepare IMP–
CBP80-associated mRNPs, the IPs using either -CBP80 antibody or rIgG
were performed in extracts of HEK293T cells transiently expressing a re-
porter mRNA (either Con-RGl or PPL-RGl) and either undepleted
or depleted of SR. After incubating the eluted proteins and the bead-
bound IMP–CBP80-bound mRNPs, in vitro-transcribed FLuc RNAs
were added as a spike-in to the obtained bead-bound or released fractions.
The relative amounts of either bead-bound or released mRNAs were quan-
tified using quantitative reverse-transcription PCR (qRT-PCR), and the
results were normalized to FLuc RNAs. (B) In vitro reconstitution assay
of IMP–CBP80-bound Con-RGl reporter mRNAs. n = 3; **P < 0.01.
(C) In vitro reconstitution assay using IMP–CBP80-bound PPL-RGl
reporter mRNAs. n = 3; *P < 0.05.
through the CBP80–SRP54 interaction. This CBC-ensured
translational repression of RNC–SRP until its proper tar-
geting to the ER is hereafter referred to as ‘CENTRE.’
Our concept of CENTRE was corroborated through ex-
periments using glutathione peroxidase 1 (GPx1) reporter
mRNAs; either Con-FLAG-GPx1 mRNA or PPL-FLAG-
GPx1 mRNA (Supplementary Figure S9A). Downregula-
tion of SR resulted in a ∼5-fold reduction in the expres-
sion of polypeptides from PPL-FLAG-GPx1 mRNA, but
not from Con-FLAG-GPx1 mRNA. However, this was re-
versed by the double downregulation of SR and CBP80
without significantly affecting the abundance of reporter
mRNAs (Figure 5A and Supplementary Figure S9B). A
similar expression pattern was observed for Myc-ER-GFP
reporter mRNA encoding a signal sequence (Figure 5B
and Supplementary Figure S9C) and DPM3-GFP reporter
mRNA (Supplementary Figure S9D and E). DPM3 mRNA
belonged to the CBP80 IP ∩ SRP68 IP group and showed a
∼4.9-fold increase in the IP of CBP80 following SR down-
regulation (Figure 2D, E, and Supplementary Table S3B).
Treating the cells with MG132, a potent proteasome in-
hibitor, did not affect the amount of expressed polypeptides,
ruling out an indirect effect on protein stability.
We also carried out a complementation assay using ei-
ther small interfering RNA (siRNA)-resistant CBP80R-
wild type (WT) or CBP80R-L34E and siRNAs against
SR and CBP80. When cells were depleted of both SR
and CBP80, expression of CBP80R-WT, but not CBP80R-
L34E, reduced the expression of polypeptides from PPL-
FLAG-GPx1 mRNA (Figure 5C) and Myc-ER-GFP re-
porter mRNA (Figure 5D) by ∼13-fold and ∼4-fold, re-
spectively, marginally affecting the abundance of reporter
mRNAs (Supplementary Figure S9F and G). These find-
ings suggest that mRNAs encoding a signal sequence are
subjected to CENTRE, and that in the event that CEN-
TRE is inefficient, CBC–RNC–SRP is easily converted to
eIF4E–RNC–SRP with the help of IMP, and the resulting
eIF4E–RNC–SRP can be promiscuously translated even
before proper targeting of RNC–SRP to the ER.
CENTRE safeguards against accumulation of protein aggre-
gates in the cytosol
What is the biological importance of CENTRE? Under
normal conditions, the intracellular distribution of Myc-
ER-GFP or DPM3-GFP largely overlapped with that of
a well-characterized ER-resident protein, Sec61 (Figure
6A and Supplementary Figure S10), which is translocated
to the ER in an SRP-independent manner (49,50). In con-
trast, double downregulation of SR and CBP80 caused
aberrant localization of Myc-ER-GFP or DPM3-GFP to
peculiar cytoplasmic aggregates that did not overlap with
Sec61 (Figure 6A, Supplementary Figures S10 and S11A).
The observed protein aggregates partially overlapped with
ubiquitin (Supplementary Figure S11B) but not with non-
membranous cytosolic aggregates (aggresomes, processing
bodies, and stress granules), autophagy puncta, and mem-
branous organelles (mitochondria and lysosomes; Supple-
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Figure 4. The CBC–RNC–SRP complex accumulates subpolysomal fractions following SR downregulation. HEK293FT cells stably expressing Myc-
eIF4E were either undepleted or depleted of SR, and then were transiently expressed with CBP80-HA and two reporter mRNAs (Con-RGl and PPL-
RGl mRNAs). The cytoplasmic extracts were then subjected to polysome fractionation experiments followed by IP with either -HA or -Myc antibody.
(A) Western blotting assay confirming specific downregulation of SR. (B) Relative distribution of IPed proteins and co-IPed reporter mRNAs in polysome-
fractionated samples. (C and D) Relative distribution of PPL-RGl mRNAs. Amounts of PPL-RGl mRNAs after the IPs were normalized to those before
IPs. Relative distribution of normalized PPL-RGl mRNAs co-immunopurified with either CBP80-HA (panel C) or Myc-eIF4E (panel D) are presented
as a percentage of normalized ratios; n = 2. (E and F) Relative distribution of Con-RGl mRNAs. As performed in (C), (D), except that the relative
distribution of normalized Con-RGl mRNAs co-immunopurified with CBP80-HA (panel E) or Myc-eIF4E (panel F) are presented as a percentage of
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Figure 5. The CBC–RNC–SRP complex is translationally repressed. (A) Protein expression from Con-FLAG-GPx1 or PPL-FLAG-GPx1 mRNA.
HEK293T cells depleted of the indicated protein were transiently transfected with one of reporter plasmids and pMS2-HA-GFP (a reference plasmid). The
cells were either untreated or treated with MG132 for 12 h before cell harvesting. The levels of the expressed proteins were normalized to MS2-HA-GFP
protein abundance. Efficient inhibition of proteasomal activity by MG132 treatment was evidenced by an increase in the abundance of endogenous p53
through its stabilization; n = 3. (B) Protein expression from Myc-ER-GFP mRNAs. As performed in panel A, except that HEK293T cells were transiently
transfected with pCMV-Myc-ER-GFP and a reference plasmid expressing N-HA-GST; n = 3. (C) Complementation experiments using CBP80R-WT
or -L34E variant and either Con-FLAG-GPx1 mRNA or PPL-FLAG-GPx1 mRNA. As performed in panel A, except that HEK293T cells, either unde-
pleted or depleted of both SR and CBP80 were transiently transfected with (i) a plasmid expressing either CBP80R-WT-HA or CBP80R-L34E-HA, (ii)
a reporter plasmid expressing Con-FLAG-GPx1 or PPL-FLAG-GPx1 mRNA, and (iii) a reference plasmid, N-HA-GST; n = 3. (D) Complementation
experiments using CBP80R-WT or -L34E and Myc-ER-GFP mRNAs. As performed in panel C, except that protein expression from Myc-ER-GFP mRNA
was analyzed; n = 3.
siRNA-resistant CBP80R-WT, but not CBP80R-L34E, re-
stored the colocalization of either Myc-ER-GFP or DPM3-
GFP with Sec61 (Figure 6A and Supplementary Figure
S10). In addition, a proximity ligation assay (PLA) showed
that SR downregulation increased PLA signals of CBP80
and SRP54 in the cytosol (Figure 6B and C), pointing to
selective accumulation of the CBC–RNC–SRP complex in
the cytosol. In contrast, PLA signals of eIF4E and SRP54
were not detectable in cells that were undepleted, depleted
of SR alone, or depleted of both SR and CBP80 (Fig-
ure 6D). Altogether, these results suggest that a failure of
CENTRE causes promiscuous synthesis of signal sequence-
containing polypeptides from RNC–SRP before its tar-
geting to the ER, resulting in accumulation of aberrant
polypeptides in the cytosol.
CENTRE mitigates a cytosolic stress response
When misfolded protein aggregates accumulate in the cy-
tosol under stress conditions, a cytosolic stress response
(CSR) typified by the heat shock response is induced to re-
store protein homeostasis (16). CSR activates heat shock
factor 1 (HSF1) and subsequently induces the transcrip-
tion of genes encoding heat shock proteins (HSPs). There-
fore, we investigated the effect of cytosolic protein aggre-
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Figure 6. Inefficient CENTRE leads to accumulation of protein aggregates. (A) Confocal imaging of the Myc-ER-GFP protein and mCherry-Sec61.
HeLa cells depleted of the indicated proteins were transiently transfected with a plasmid expressing Myc-ER-GFP, a reference plasmid expressing mCherry-
Sec61, and HA, CBP80R-WT-HA, or CBP80R-L34E-HA. Scale bar, 10 m; n = 3. (B and C) PLA for CBP80 and SRP54. HeLa cells, either undepleted
or depleted of SR, were subjected to PLA (B) Quantitation of PLA signals for endogenous CBP80 and SRP54. More than 50 cells from three biological
replicates were quantitated. (C) PLA images. The antibodies raised in a mouse or rabbit are colored in yellow or red, respectively. mIgG, nonspecific mouse
IgG; rIgG, nonspecific rabbit IgG; scale bar, 10 m; n = 3. (D) PLA for eIF4E and SRP54. A previously known interaction between Y14 and MAGOH
served as a positive control; n = 3; scale bar, 10 m.
Double downregulation of SR and CBP80 significantly
promoted CSR (transcriptional induction of HSP mRNAs)
and delayed the restoration time of CSR following heat
shock, compared with single downregulation (Figure 7A).
The observed effects were reversed by HSF1 downregu-
lation (Figure 7B and C), suggesting that the CSR pro-
moted by double downregulation is mediated by HSF1.
In addition, the enhancement in CSR observed follow-
ing double downregulation was significantly attenuated by
the expression of CBP80R-WT, but not of the CBP80R-
L34E variant (Figure 7D and E). Of note, complementation
with CBP80R-WT, but not with CBP80R-L34E, blocked
the phosphorylation induced by double downregulation at
the S326 residue of HSF1 (Figure 7D), suggesting that the
phosphorylation at S326, a previously characterized key
residue that is phosphorylated upon HSF1 activation (51),
is involved in the CSR promoted by double downregula-
tion. These data indicate that the cytosolic protein aggre-
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Figure 7. Inefficient CENTRE promotes a cytosolic stress response. (A) Effects of single downregulation (of either SR or CBP80) or double downregu-
lation (of both SR and CBP80) on the CSR. HeLa cells depleted of the indicated proteins were either untreated or treated with heat shock at 42◦C for 30
min and then recovered at 37◦C for the indicated periods. The levels of HSP mRNAs were normalized to those of endogenous GAPDH mRNA. Normal-
ized levels of HSP mRNAs in undepleted cells treated with heat shock and restored for 0 h were arbitrarily set to 1.0. HS, heat shock; n = 3; *P < 0.05;
**P < 0.01. (B and C) Effects of HSF1 downregulation on the CSR induced by CENTRE failure. As performed in panel A, except that HeLa cells were
either undepleted or depleted of the indicated proteins. The normalized levels of HSP mRNAs in undepleted cells treated with heat shock and restored
for 1 h were arbitrarily set to 1.0. HS, heat shock; n = 3; **P < 0.01. (B) Western blotting showing specific downregulation. (C) Relative levels of HSP
mRNAs. (D and E) The complementation experiment. HeLa cells depleted of the indicated proteins were transiently transfected with a plasmid expressing
CBP80R-WT-HA or CBP80R-L34E-HA. Then, the cells were either untreated or treated with heat shock at 42◦C for 30 min and then recovered at 37◦C for
1 h. (D) Western blotting confirming specific downregulation of endogenous CBP80 and comparable expression of siRNA-resistant CBP80R-WT-HA or
CBP80R-L34E-HA. HS, heat shock; p-HSF1, phosphorylated HSF1. (E) Relative levels of HSP mRNAs. Normalized levels of HSP mRNAs in undepleted
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Figure 8. RNC–SRP misassembled on an mRNA coding for a mitochondrial protein is subject to CENTRE. (A) Gene ontology (GO) analysis of highly
ranked transcripts (386; fold change ≥ 1.5) in Figure 2D, E. (B–D) Effects of single downregulation of SR or double downregulation of both SR and
CBP80 on protein expression of PAM16-GFP mRNAs (panel B), intracellular ADP/ATP ratio (panel C), and mitochondrial membrane potential (panel
D). TMRE, tetramethylrhodamine, ethyl ester. (E and F) Complementation using CBP80R-WT or CBP80R-L34E. Cells depleted of the indicated proteins
were transiently expressed with siRNA-resistant CBP80R-WT-HA or CBP80R-L34E-HA. The intracellular ADP/ATP ratio (panel E) and mitochondrial
membrane potential (panel F) were analyzed; n = 3; *P < 0.05; **P < 0.01; n.s., not significant. (G) Summary of the role of CENTRE during inefficient
targeting of RNC–SRP to the ER.
The CENTRE pathway targets the RNC–SRP complex mis-
assembled on an mRNA encoding a mitochondrial protein
As mentioned above, we proposed that CENTRE func-
tions as a surveillance pathway that maintains CBC–RNC–
SRP as a translationally inactive complex until it is prop-
erly delivered to the ER. To identify the major substrates
subject to CENTRE, we performed Gene Ontology (GO)
analysis of the 1533 mRNAs belonging to the CBP80 IP
∩ SRP68 IP group (Figure 2D, E, and Supplementary Ta-
ble S3B). The set of mRNAs with the highest enrichment
in the IP of CBP80 following SR downregulation included
those associated with GO terms related to mitochondria
(Figure 8A). Indeed, protein expression from highly ranked
mRNAs associated with GO terms related to mitochon-
dria (PAM16, SLC25A41 and ATP5E) was significantly in-
hibited by SR downregulation, but this was reversed by
the double downregulation without affecting mRNA abun-
dance (Figure 8B and Supplementary Figure S12). In agree-
ment with the protein expression results, SR downregula-
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Figure 9. Proposed model of CENTRE. See the Discussion section for details.
ure 8C) and a decrease in membrane potential (Figure 8D),
indicative of mitochondrial dysfunction. Notably, double
downregulation restored mitochondrial function. This was
reversed by complementation with CBP80R-WT, but not
with CBP80R-L34E (Figure 8E and F). In addition, the
intracellular distribution of PAM16-GFP protein largely
overlapped with that of mitochondria (stained by Mito-
Tracker) under normal conditions or conditions depleted
of both SR and CBP80 (Supplementary Figure S13). On
the other hand, complementation with CBP80R-WT, but
not with CBP80R-L34E, caused inappropriate intracellular
distribution of PAM16-GFP. Given that signal sequences
for ER and mitochondrial targeting share the N-terminal
-helical structure, but with different hydrophobicity lev-
els (52), there may be non-specific interaction between SRP
and the mitochondrial targeting sequence. Therefore, these
results suggest that misassembled RNC–SRP on an mRNA
encoding a mitochondrial protein is also translationally re-
pressed by the CENTRE pathway when it is not efficiently
targeted to the ER surface, resulting in mitochondrial dys-
function (Figure 8G).
DISCUSSION
Cellular proteins destined for the ER are subjected to rig-
orous quality control to ensure proper targeting of the pro-
teins (2–4). As a nascent chain harboring a signal sequence
exits a ribosome, the RNC is recognized and translation-
ally arrested by an SRP. It resumes translation elongation
on the surface of the ER only after the RNC–SRP com-
plex is properly delivered to the ER. In contrast, when the
signal sequence does not contain the sufficient number of
hydrophobic residues, the mutated signal sequence fails to
associate with the SRP. In this case, AGO2 binds to the mu-
tated nascent chain and initiates rapid mRNA decay in a
process called RAPP (19). Although RNC–SRP success-
fully passes RAPP, efficient translocation of the RNC–SRP
complex is hampered by the intracellular concentration of
the SR, which is known to be rate-limiting for ER targeting
(17).
In this study, we unravel a co-translational quality control
pathway, CENTRE, via which the CBC ensures strict main-
tenance of the RNC–SRP complex in a translationally-
repressed, translocation-competent state until the RNC–
SRP complex is properly delivered to the ER (Figure 9).
When CENTRE is impaired or inefficient, IMP triggers
promiscuous replacement of the CBC by eIF4E, even before
the CBC–RNC–SRP complex is delivered to the ER. The
resulting eIF4E–RNC–SRP complex synthesizes aberrant
polypeptides at inappropriate cellular locations. Eventually,
the accumulated aberrant and misfolded-polypeptide aggre-
gates induce CSR, which is associated with many neurode-
generative pathologies, including Alzheimer’s and Parkin-
son’s diseases (14–16).
We also found that the CENTRE pathway targets a
CBC–RNC–SRP complex misassembled on an mRNA en-
coding a mitochondrial protein (Figure 8). When the re-
pressed complex reaches the ER surface, it is disassem-
bled via a recently discovered surveillance mechanism,
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mRNA can then be recycled in a new round of translation
for proper mitochondrial targeting. In this way, during pio-
neer translation, CENTRE functions as a surveillance path-
way that ensures proper targeting of proteins destined for
the ER or mitochondria.
The tight regulation of the proper sorting of newly syn-
thesized proteins into diverse membranous organelles and
non-membranous structures is necessary for various cel-
lular functions (5,54). Comprehensive elucidation of the
mechanisms underlying subcellular localization of proteins
is therefore crucial for a complete understanding of cell bi-
ology. In this study, we propose CENTRE as a quality con-
trol pathway specific for targeting to the ER or mitochon-
dria. Molecular mechanisms involved in targeting proteins
to other subcellular locations are likely to be under unique
quality control systems which need to be investigated in fu-
ture studies.
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